Curanex Pharmaceuticals Inc Common Stock Stock Analysis & AI Score
Curanex Pharmaceuticals Inc Common Stock (CURX) has an ST Score of 24.8 (D+), driven by its Financial Strength (B) and held back by its Growth (F). CURX last traded at $4.45.
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Curanex Pharmaceuticals Inc Common Stock (CURX) has an ST Score of 24.8 (D+), driven by its Financial Strength (B) and held back by its Growth (F). CURX last traded at $4.45.
- Strongest
- Financial StrengthB
- Weakest
- GrowthF
All factor grades
- Financial StrengthB
- ValuationC-
- MomentumC-
- ProfitabilityF
- GrowthF
- Piotroski2/9
Contact
CURX stock: frequently asked questions
What is CURX's ST Score?
Curanex Pharmaceuticals Inc Common Stock (CURX) has an ST Score of 24.8 (D+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is CURX a buy, hold, or sell?
Our ST Score grades it D+ (24.8/100). The ST Score is a data-driven signal, not a recommendation.
What are CURX's factor grades?
Valuation C-, Profitability F, Financial Strength B, Momentum C-, Growth F.
What is CURX's valuation grade?
Curanex Pharmaceuticals Inc Common Stock (CURX) earns a valuation grade of C-, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is CURX's growth grade?
Curanex Pharmaceuticals Inc Common Stock (CURX) earns a growth grade of F, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is CURX's profitability grade?
Curanex Pharmaceuticals Inc Common Stock (CURX) earns a profitability grade of F, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is CURX's financial strength grade?
Curanex Pharmaceuticals Inc Common Stock (CURX) earns a financial strength grade of B, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is CURX's Piotroski score?
Curanex Pharmaceuticals Inc Common Stock (CURX) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.